Today: 8 February 2026
Subscribe
Browse Category

TSX:6758.T News 10 July 2025

The Ultimate 2025 (Q1) Flagship Smartphone Showdown: Apple vs Samsung vs Google & More

The Ultimate 2025 (Q1) Flagship Smartphone Showdown: Apple vs Samsung vs Google & More

Apple’s iPhone 15 Pro series uses a Grade 5 titanium frame replacing stainless steel, making it about 18 grams lighter than the previous model. Samsung’s Galaxy S24 Ultra features a reinforced titanium alloy chassis and a large camera housing with built-in S-Pen. Google Pixel 9 Pro supplies a 6.7-inch flat OLED display at 1344×2992 resolution (~490+ ppi), 1–120 Hz LTPO, and up to 2400 nits peak brightness. OnePlus 13 introduces Ceramic Guard glass with IP69 water/dust resistance and a nano-scale silicon battery structure enabling a slimmer build. Xiaomi 14 Pro and Oppo Find X7 Ultra offer vegan leather back accents
10 July 2025
······

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Go toTop